Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWolf Minerals Regulatory News (WLFE)

  • There is currently no data for WLFE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR SHAREHOLDING

29 Mar 2018 11:48

RNS Number : 4214J
Wolf Minerals Limited
29 March 2018
 

29 March 2018

 

WOLF MINERALS LIMITED

 

("WLFE" or the "Company")

 

DIRECTOR SHAREHOLDING

 

Wolf Minerals Limited (AIM: WLFE), has today issued to a person closely associated with Mr Nick Clarke, Non-Executive Director, 96,000 ordinary shares of no par value in the Company ("Ordinary Shares") in lieu of fees at a rate of A$ 0.0625 per Ordinary Share under the Wolf Minerals Limited Directors' Share Plan as approved by shareholders on 28 November 2017.

 

Following the above transaction, Mr Nick Clarke has an interest in a total of 700,678 Ordinary Shares, representing approximately 0.06 per cent of the issued share capital of the Company.

 

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated Reason for the notification

 

a)

Name

Nick Clarke

 

 

2

Reason for the notification

 

a)

Position/status

Non-Executive Director

 

 

b)

Initial notification

/Amendment

Initial Notification

 

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Wolf Minerals Limited

 

b)

LEI

213800F9EQEDKGDKZM06

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of  the financial instrument, type of instrument

 

 

Identification code

 

Fully Paid Ordinary Shares of no par value

 

 

 

ISIN Code of Wolf Minerals Limited Ordinary Shares: AU000000WLF3

 

 

b)

Nature of the transaction

Issue of securities under the Wolf Minerals Limited Directors' Share Plan as approved by shareholders on 28 November 2017.

 

 

 

c)

Price(s) and volume(s)

 

Prices

Volumes

A$ 0.0625

(equivalent to ~3p)

96,000

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

96,000

 

AUD $6,000

e)

Date of the transaction

29 March 2018

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHPGUBWWUPRGUB
Date   Source Headline
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:02 amRNSAppendix 3Y
30th Jun 20177:01 amRNSAppendix 3Y
30th Jun 20177:01 amRNSIssue of Equity and Change of Directors' Interests
29th Jun 20179:15 amRNSReplacement of Grant of ASX Listing Rule Waivers
28th Jun 20173:15 pmRNSASX Listing Waivers for Bridge Facility Increase
28th Jun 20173:15 pmRNSBridge Facility with RCF Increased
16th Jun 20177:00 amRNSIssue of Equity
16th Jun 20177:00 amRNSAppendix 3B
16th May 20177:00 amRNSCancellation of Lapsed Performance Rights
15th May 20179:05 amRNSAppendix 3Z
15th May 20179:05 amRNSResignation of Director
8th May 20177:00 amRNSAppendix 3X
8th May 20177:00 amRNSInterim MD, Richard Lucas, Appointed to Wolf Board
28th Apr 20177:00 amRNSAppendix 5B
28th Apr 20177:00 amRNSQuarterly Activities Report
7th Apr 201710:19 amRNSDirectorate Change
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSCleansing Notice Letter
4th Apr 20177:00 amRNSIssue of Equity and Change of Directors' Interests
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSAppendix 3Y
4th Apr 20177:00 amRNSAppendix 3B
4th Apr 20177:00 amRNSAppendix 3Y
16th Mar 20177:02 amRNSInterim Financial Statements
13th Mar 20177:35 amRNSUpdate on Bridge Facility with RCF
20th Feb 20174:41 pmRNSSecond Price Monitoring Extn
20th Feb 20174:35 pmRNSPrice Monitoring Extension
10th Feb 20179:20 amRNSCancellation of Lapsed Performance Rights
6th Feb 20177:00 amRNSRevised Securities Dealing Policy
31st Jan 20177:00 amRNSAppendix 5B
31st Jan 20177:00 amRNSQuarterly Activities Report
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSCleansing Notice Letter
30th Dec 20168:10 amRNSDirector/PDMR Shareholding
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3B
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:10 amRNSAppendix 3Y
30th Dec 20168:09 amRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20161:15 pmRNSIssue of Equity and Change of Directors' Interests
22nd Dec 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.